From: Associated Press, March 24, 2004
"The first generic versions of the potent painkiller
OxyContin have been approved for market, a move likely to help patients with long-term pain save money on the drug that has been illegally used by drug abusers.
"OxyContin is a long-lasting version of
oxycodone, a narcotic considered important therapy for many patients suffering long-term, severe pain from illnesses such as cancer. The tablet, when swallowed whole, provides 12 hours of pain relief.
"But the drug can produce a quick and potentially lethal high if it is chewed, snorted or injected. It has been linked to more than 100 deaths and bears the governmentâs strongest warning label, which says the drug may be as addictive as
morphine.
"Abuse of OxyContin is a serious law-enforcement problem, but its cost â hundreds of dollars a month â has had patients who depend on its pain relief anxiously awaiting generic competition.
"Late Tuesday, the Food and Drug Administration cleared Teva Pharmaceuticals and Endo Pharmaceuticals to sell generic versions of extended-release oxycodone. As a condition, the companies must include abuse warnings, doctor education and other steps aimed at minimizing illegal use that are similar to the risk-management program run by OxyContin maker, Purdue Pharma.
"Itâs unclear when the generic versions will go on the shelves. A federal judge recently ruled some OxyContin patents unenforceable, clearing the way for generic competition, but Purdue Pharma has filed legal notice that it will appeal..."